• Fludarabine: A Decision Framework for Assay Design

  2026-08-25

  Fludarabine is a DNA synthesis inhibitor whose enzyme-level activity can be translated into more informative oncology assays. This guide connects replication blockade, apoptosis readouts, and genotype-aware model selection while defining practical handling parameters.

• Betulinic Acid Protects Against Cyclophosphamide Liver Injur

  2026-08-25

  This 2025 Environmental Toxicology study links betulinic acid protection against cyclophosphamide-induced liver injury to coordinated control of NRF2 antioxidant signaling, ERK–MAPK activity, mitochondrial dynamics, and apoptosis. Its PD98059 intervention strengthens the interpretation that ERK-mediated mitochondrial apoptosis is an important mechanistic component, while also highlighting the limits of extrapolating pharmacological pathway inhibition from mice to human therapy.

• Antipyrine in Translational BBB Research

  2026-08-24

  Antipyrine can serve as a practical translational anchor between pain and fever biology, pharmacokinetic studies, and modern blood-brain barrier workflows. This article explains how to use 1,5-dimethyl-2-phenylpyrazol-3-one strategically in mechanistic assays without overstating what permeability data can prove.

• DiscoveryProbe FDA-approved Drug Library Workflow

  2026-08-24

  Turn a clinically annotated compound collection into a mechanism-driven screen for stress signaling, proteostasis, and therapeutic repositioning. This workflow combines the DiscoveryProbe FDA-approved Drug Library with orthogonal phenotypes, pathway controls, and practical troubleshooting for HTS, HCS, and disease-model validation.

• Difloxacin HCl for AST and Resistance Studies

  2026-08-23

  Difloxacin HCl supports two distinct research workflows: quantitative antimicrobial susceptibility testing through bacterial DNA replication inhibition and exploratory studies of multidrug resistance reversal. This guide connects compound handling, assay design, controls, and troubleshooting with practical lessons from mitotic checkpoint research without conflating the evidence bases.

• H-89: A Translational Lens on PKA and Osteogenesis

  2026-08-22

  A thought-leadership guide to using H-89 as a mechanistic perturbation tool for connecting Wnt, cAMP–PKA signaling, O-GlcNAcylation, glycolysis, and osteogenesis while maintaining translational rigor.

• Baicalin: From Cortical Plasticity to Translation

  2026-08-22

  Baicalin is emerging as a mechanistically versatile research tool at the intersection of neuroplasticity, oxidative stress biology, and cancer research. New mouse data show that it can reactivate ocular dominance plasticity in adult amblyopia, while established pathway-focused evidence supports investigation of KEAP1-NRF2/HO-1 pathway modulation, TGF-β1/p-Smad3 pathway inhibition, non-small cell lung cancer sensitization, and breast cancer metastasis suppression. This article translates those findings into experimental priorities, formulation considerations, and go/no-go criteria for translational teams.

• miR-24-3p/Sp1/PI3K Axis in Heart Failure

  2026-08-21

  The reference study identifies miR-24-3p as an upstream regulator of doxorubicin-induced cardiac injury and links its silencing to restoration of Sp1/PI3K signaling. Using complementary rat and H9c2 cell models, the authors connect this axis with cardiac dysfunction, apoptosis, oxidative stress, and direct miRNA targeting of Sp1.

• BV6 IAP Antagonist: Cancer Research Workflows

  2026-08-20

  BV6 is a Smac mimetic IAP antagonist for probing apoptosis, therapy sensitization, and immune-mediated cytotoxicity in cancer models. This workflow-led guide connects dose preparation, time-resolved readouts, radiosensitization studies, and the reference study’s caution against relying on a single cell-death marker.

• KCNE4 Modulation of Kv1.3 Blocker Pharmacology

  2026-08-20

  The reference study shows that the leukocyte ancillary subunit KCNE4 changes the inhibition kinetics of Kv1.3 by the intracellular blocker Psora-4 without measurably changing blocker affinity. Its findings establish channel-complex architecture, not only pore-forming subunit identity, as a critical variable in pharmacological studies of immune Kv1.3.

• SN-38 Beyond TOP1: A Translational Roadmap

  2026-08-19

  7-Ethyl-10-hydroxycamptothecin, also known as SN-38, offers translational researchers a way to study DNA topoisomerase I trapping alongside FUBP1–FUSE disruption. This article connects mechanism, model selection, assay design, and research-use strategy for advanced colon cancer research while distinguishing established evidence from testable hypotheses.

• LINC02870 Drives SNAIL Translation in HCC

  2026-08-19

  The reference study identifies LINC02870 as a potentially oncogenic lncRNA in hepatocellular carcinoma and links it to EIF4G1-dependent enhancement of SNAIL translation. Its integrated expression, prognosis, interaction, and cell-phenotype analyses provide a mechanistic framework for studying how noncoding transcripts influence metastatic behavior, particularly in HBV-associated disease.

• Dinaciclib and the Mechanics of Tissue Boundaries

  2026-08-18

  Dinaciclib (SCH727965) is more than a potent CDK inhibitor for cell-cycle and apoptosis studies. This article examines how its multi-CDK activity can be used to test the mechanical consequences of cell division while separating boundary remodeling from cytotoxicity.

• Sodium-Driven Mitochondrial Failure in NECSO

  2026-08-18

  Qiao and colleagues identify mitochondrial energy failure as a central execution mechanism in sodium-overload necrosis (NECSO), linking TRPM4-mediated Na+ entry to NCLX-dependent mitochondrial ion imbalance, suppressed oxidative phosphorylation, and ATP depletion. The findings provide a mechanistic framework for studying how ion dysregulation collapses cellular energy maintenance and causes swelling and lysis.

• Difloxacin HCl in Resistance Research

  2026-08-17

  Difloxacin HCl supports two distinct bench applications: antimicrobial susceptibility testing through bacterial DNA replication inhibition and cell-based studies of multidrug resistance reversal. This guide translates its chemistry and the p31comet–Plk1 checkpoint findings into practical workflows, controls, and troubleshooting decisions.

8585 records 1/573 page Next 12345 下5页 Last page